- Home
- COEP vs TURN Comparison
COEP vs TURN Comparison
Compare COEP & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- TURN
- Stock Information
- Founded
- COEP 2017
- TURN 1981
- Country
- COEP United States
- TURN United States
- Employees
- COEP N/A
- TURN N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- TURN Finance/Investors Services
- Sector
- COEP Health Care
- TURN Finance
- Exchange
- COEP Nasdaq
- TURN Nasdaq
- Market Cap
- COEP 32.4M
- TURN 39.6M
- IPO Year
- COEP N/A
- TURN N/A
- Fundamental
- Price
- COEP $10.45
- TURN $3.72
- Analyst Decision
- COEP
- TURN
- Analyst Count
- COEP 0
- TURN 0
- Target Price
- COEP N/A
- TURN N/A
- AVG Volume (30 Days)
- COEP 60.3K
- TURN 38.0K
- Earning Date
- COEP 05-09-2025
- TURN 05-12-2025
- Dividend Yield
- COEP N/A
- TURN N/A
- EPS Growth
- COEP N/A
- TURN N/A
- EPS
- COEP N/A
- TURN N/A
- Revenue
- COEP N/A
- TURN $194,813.00
- Revenue This Year
- COEP N/A
- TURN N/A
- Revenue Next Year
- COEP N/A
- TURN N/A
- P/E Ratio
- COEP N/A
- TURN N/A
- Revenue Growth
- COEP N/A
- TURN 254.25
- 52 Week Low
- COEP $2.31
- TURN $3.12
- 52 Week High
- COEP $13.70
- TURN $4.40
- Technical
- Relative Strength Index (RSI)
- COEP 48.25
- TURN 36.71
- Support Level
- COEP $10.00
- TURN $3.67
- Resistance Level
- COEP $11.75
- TURN $3.90
- Average True Range (ATR)
- COEP 1.07
- TURN 0.11
- MACD
- COEP -0.12
- TURN -0.03
- Stochastic Oscillator
- COEP 48.22
- TURN 28.26
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.